U.S. Physical Therapy, Inc. (USPH)
NYSE: USPH · Real-Time Price · USD
76.46
-1.25 (-1.61%)
Aug 6, 2026, 4:00 PM EDT - Market closed
U.S. Physical Therapy Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,141 | 1,181 | 1,339 | 1,396 | 1,054 | 1,234 | |
Market Cap Growth | 6.75% | -11.81% | -4.07% | 32.50% | -14.60% | -20.17% |
Enterprise Value | 1,502 | 1,754 | 1,863 | 1,678 | 1,486 | 1,585 |
Last Close Price | 76.46 | 78.09 | 88.71 | 93.14 | 81.03 | 95.55 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 428.97 | 54.99 | 48.21 | 72.77 | 36.01 | 39.65 |
Forward PE | 22.69 | 27.67 | 32.93 | 34.02 | 29.15 | 30.02 |
PEG Ratio | 1.92 | 3.27 | 3.86 | 4.61 | 3.24 | 2.50 |
PS Ratio | 1.42 | 1.51 | 1.99 | 2.31 | 1.90 | 2.49 |
PB Ratio | 2.54 | 2.48 | 2.74 | 2.93 | 3.34 | 4.17 |
P/FCF Ratio | 17.81 | 19.36 | 20.36 | 19.20 | 20.95 | 18.09 |
P/OCF Ratio | 13.74 | 15.73 | 17.87 | 17.03 | 18.00 | 16.15 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.87 | 2.25 | 2.78 | 2.77 | 2.69 | 3.20 |
EV/EBITDA Ratio | 15.12 | 16.02 | 22.69 | 25.18 | 20.68 | 19.26 |
EV/EBIT Ratio | 19.63 | 20.24 | 29.57 | 33.21 | 26.16 | 22.44 |
EV/FCF Ratio | 23.44 | 28.76 | 28.33 | 23.08 | 29.55 | 23.24 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.44 | 0.34 | 0.32 | 0.33 | 0.52 | 0.42 |
Debt / EBITDA Ratio | 3.88 | 2.88 | 3.60 | 3.88 | 4.11 | 2.71 |
Debt / FCF Ratio | 6.02 | 5.17 | 4.49 | 3.56 | 5.87 | 3.27 |
Net Debt / Equity Ratio | 0.80 | 0.59 | 0.52 | 0.22 | 0.84 | 0.66 |
Net Debt / EBITDA Ratio | 3.63 | 2.55 | 3.09 | 1.59 | 3.67 | 2.36 |
Net Debt / FCF Ratio | 5.63 | 4.59 | 3.86 | 1.46 | 5.25 | 2.85 |
Asset Turnover | 0.66 | 0.66 | 0.62 | 0.65 | 0.69 | 0.74 |
Quick Ratio | 1.12 | 0.89 | 1.09 | 2.18 | 1.17 | 1.09 |
Current Ratio | 1.27 | 1.01 | 1.18 | 2.28 | 1.30 | 1.14 |
Return on Equity (ROE) | 6.49% | 7.59% | 6.46% | 6.55% | 9.26% | 13.43% |
Return on Assets (ROA) | 4.61% | 5.45% | 4.41% | 4.10% | 5.52% | 8.32% |
Return on Invested Capital (ROIC) | 5.04% | 6.26% | 5.39% | 5.05% | 6.36% | 9.85% |
Return on Capital Employed (ROCE) | 6.94% | 8.19% | 6.47% | 6.06% | 7.90% | 12.11% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.23% | 1.82% | 2.07% | 1.37% | 2.78% | 2.52% |
FCF Yield | 5.62% | 5.16% | 4.91% | 5.21% | 4.77% | 5.53% |
Dividend Yield | 2.41% | 2.31% | 1.99% | 1.83% | 2.03% | 1.52% |
Payout Ratio | 1048.07% | 69.13% | 84.46% | 85.44% | 66.30% | 45.96% |
Buyback Yield / Dilution | -0.18% | -0.74% | -6.17% | -9.26% | -0.67% | -0.49% |
Total Shareholder Return | 2.23% | 1.57% | -4.19% | -7.44% | 1.35% | 1.03% |